Cherry Street Pharmacy

Cherry Street Pharmacy

Early Stage

One-stop pharmacy that has filled over 72,000 prescriptions since April 2019

One-stop pharmacy that has filled over 72,000 prescriptions since April 2019


Raised to Date: Raised: $111,375

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Convertible Note



SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap




Rolling Commitments ($USD)

Reporting Date


Days Remaining
% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



Tulare, California

Business Type

Life Style

Cherry Street Pharmacy, with a $15 million valuation cap, is raising funds on MicroVentures. It is a one-stop pharmacy that delivers healthcare services to underserved areas. It offers services, including personalized health programs, prescription delivery, pet care, and health content. Dr. Wenbo Liu founded Cherry Street Pharmacy in 2017. The proceeds of the current crowdfunding campaign, with a minimum raise of $25,000 and a maximum raise of $1,070,000, will be used for campaign marketing, general marketing, research and development, equipment, future wages, and general working capital. Cherry Street Pharmacy has filled over 72,000 prescriptions since April 2019, with a record-high of 5,800 prescriptions filled in June 2020. The pharmacy plans to expand into a second location by 2021.

Summary Profit and Loss Statement

Most Recent Year Prior Year












Net Income



Summary Balance Sheet

Most Recent Year Prior Year




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 08/18/2020
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article


The KingsCrowd investment team wanted to provide research on Cherry Street Pharmacy although it was not selected as a Top Deal or Deal to Watch. If you have questions regarding our deal diligence or selection methodology, please reach out to

The Cherry Street Pharmacy founder is part of traditionally underrepresented groups in startup investing.

Analysis written by Katy Dolan.

Next Section: Problem


U.S. pharmacies’ dispensing revenues totalled $423.7 billion in 2018. Prescription drugs are a massive market, because more than 131 million people in the U.S. alone use prescription drugs — that’s more than 65% of all American adults. Prescription drugs in the U.S. are notoriously expensive, more so than in any other country in the world. In short, distributing prescription drugs is a massive opportunity due to the prevalence and value of such medications. 

Until recently though, pharmacies were stuck in the 20th century. Obtaining prescription medication was (and still can be) an arduous process that involves a doctor’s visit, waiting for a prescription to be filed and filled at a local pharmacy, and picking up the medication there. That entire process might need to be done monthly or even more frequently for those that suffer from chronic medical conditions. 

Technological innovation has begun to impact pharmacy business models. Telemedicine has the potential to replace the core services of traditional pharmacies. Online pharmacies like GoodRX and PillPack can ship medicine directly to consumers’ doors with significantly less hassle. Particularly given the telemedicine and home delivery trends of the coronavirus pandemic, pharmacies are in a pivotal inflection point. How can consumers receive medication efficiently in this new age?

Next Section: Solution


Cherry Street Pharmacy is a brick-and-mortar pharmacy in Tulare, CA that provides prescription medications to patients in the medically-under-resourced Central Valley region of California. 

Cherry Street differentiates itself from traditional boutique pharmacies by offering additional products — over-the-counter medications as well as pet drugs. It also provides services like personalized health programs to patients, with some online integration to provide convenient support. The Cherry Street mobile app allows patients to check the status of prescriptions, browse health content, and communicate directly with pharmacists. Cherry Street also offers free delivery to patients in the local area, eliminating the need for in-store visits entirely. 

Cherry Street began operating in 2017 and has filled over 72,000 prescriptions to date. The company has experienced growth in recent months, with over 5,800 prescriptions filled in June 2020 alone. Detailed financial information for Cherry Street Pharmacy is unavailable, as the company is pursuing crowdfunding on the accelerated schedule allowed by COVID-19 small business relief programs.

Next Section: Team


Cherry Street Pharmacy was founded by Dr. Wenbo Liu, who holds a Doctor of Pharmacy degree from the University of Hawaii. After graduating from pharmaceutical school, Liu worked for Walmart in its specialist pharmacy program, collaborating on Walmart’s pharmacy expansion in multiple states.

Next Section: Other

Growth Plan

In the immediate term, Cherry Street plans to expand by opening a second brick-and-mortar pharmacy location in 2021. The company is exploring other underserved areas for this second location, either building from the ground-up or purchasing an existing pharmacy. 

In the long term, Cherry Street plans to expand its online offerings to lean more heavily on telemedicine and virtual pharmacy services. The company plans to hire healthcare professionals — like nurses and nurse practitioners — to provide services through the Cherry Street telemedicine portal. These services would presumably integrate directly with the Cherry Street Pharmacy to provide convenient prescription drugs with free home delivery.

Next Section: Rating


Cherry Street Pharmacy displays both positive and negative signals for prospective investors to consider, which balance out to a neutral rating. 

On the positive side, Cherry Street has proven traction in prescription filling — over 72,000 prescriptions filled is no small feat. The company is also highly focused on differentiation within the pharmacy space. Founder Wenbo Liu seems committed to exploring additional verticals to complement existing business. For example, the pharmacy offers at-home delivery, a bespoke touch expected from a local community pharmacy, but less so from a legacy provider like CVS or Walgreens. Cherry Street is also clearly envisioning a digital future with additional telemedicine services, which would likely better sustain growth than solely in-person operations.

On the other hand, Cherry Street is currently a brick-and-mortar location with limited online differentiation. While setting forth the goal of comprehensive telemedicine and online pharmacy services is admirable, prospective investors may wonder whether Cherry Street has the resources needed to execute such programs effectively. Building effective and HIPAA-compliant telemedicine portals is a sizable task that is perhaps better suited for a technology-focused company rather than a traditional products business. Cherry Street also faces stiff competition from massive companies intensely focused on reinventing pharmaceutical services, including incumbent players CVS and Walgreens, and new entrants like Amazon (whose 2018 acquisition of PillPack indicates a newfound commitment to online health). In addition, the lack of financial information about Cherry Street’s revenue traction makes any performance projections difficult. 

In sum, Cherry Street Pharmacy has demonstrated success as a local brick-and mortar pharmacy, but the company’s long-term success as a modern telemedicine provider is difficult to predict. Investors may reap mild returns as the business expands retail operations, but Cherry Street is unlikely to become an extremely valuable business. Therefore, this is a Neutral deal.

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Cherry Street Pharmacy on MicroVentures
Platform: Microventures
Security Type: Convertible Note
Valuation: $13,000,000

Follow company

Follow Cherry Street Pharmacy on MicroVentures

Buy Cherry Street Pharmacy's Deal Report

Warning: according to the close date for this deal, Cherry Street Pharmacy may no longer be accepting investments.

Cherry Street Pharmacy Deal Report

Get KingsCrowd’s comprehensive report on Cherry Street Pharmacy including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Cherry Street Pharmacy is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Cherry Street Pharmacy deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge